Soligenix Profile

2.02
USD 0.02  1.00%
16%
0%

Acquisition by Oreola Donini of 35000 shares of Soligenix subject to Rule 16b-3

Soligenix Inc insider trading alert for grant of option (right to buy) by Oreola Donini, SVP and CSO, on December 11, 2017. This event was filed by Soligenix Inc with SEC on 2017-12-11. Statement of changes in beneficial ownership - SEC Form 4. Oreola Donini is currently serves as chief scientific officer and sr. vp of Soligenix Inc [view details]   

Soligenix Summary

Soligenix Inc (SNGX) is traded on Nasdaq Capital Markets in USA. It is located in NEW JERSEY, U.S.A and employs 19 people. Soligenix Inc was previously known as Soligenix Inc and was traded on Nasdaq Capital Markets under the symbol SNGX. Soligenix is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 17.9 M. Soligenix Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 8.73 M outstanding shares of which 557.94 K shares are at this time shorted by private and institutional investors with about 3.36 trading days to cover. SOLIGENIX currently holds about 5 M in cash with (5.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Soligenix Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Knoll Capital Management LpCommon Shares870 K1.8 M
Panagora Asset Management IncCommon Shares33.8 K75 K
Susquehanna International Group LlpWarrants61 K49 K
View Soligenix Diagnostics

Selected Soligenix Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Soligenix Against Markets

  The entity Soligenix Inc with a symbol SNGX was delisted from Nasdaq Capital Markets. Please use Soligenix Inc with a symbol SNGX from now on.

Directors

Soligenix Corporate Directors
Jerome Zeldis Independent Director
Marco Brughera Director
Gregg Lapointe Independent Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Soligenix Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.85March 23, 2017
Soligenix Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Soligenix Corporate Directors
Jerome Zeldis Independent Director
Marco Brughera Director
Gregg Lapointe Independent Director